Safety and Efficacy of Intravenous Valproate in Pediatric Status Epilepticus and Acute Repetitive Seizures

• Conditions: Status Epilepticus
• Interventions: Drug: Valproate

• Registration Number: NCT01268904
• Lead Sponsor: Hillel Yaffe Medical Center

Brief Summary

To evaluate the safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures as part of seizure treatment protocol in pediatric ER

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-12
• Study First Submitted: 2010-12-30
• Study First Submitted QC: 2010-12-30
• Last Update Submitted: 2010-12-30
• Study First Posted: 2010-12-31
• Last Update Posted: 2010-12-31
• Study Start: 2011-01
• Primary Completion: 2013-07
• Study Completion: 2013-08

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Child with clinical presentation of status epilepticus

Exclusion Criteria

• All others

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Pediatric status epilepticus	Valproate	-

Primary Outcome Measures

Name	Time	Method
Safety of intravenous valproate in pediatric status epilepticus	One week

Secondary Outcome Measures

Name	Time	Method
Efficacy of intravenous valproate in pediatric status epilepticus	One week

Trial Locations

Locations (1)

Hillel Yaffe Medical Center; 🇮🇱 Hadera, Israel